--- title: "FEMASYS INC (FEMY) stock listing, news and investor profile" url: "https://aibio.space/companies/femasys/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "FEMASYS INC (NASDAQ: FEMY), United States. Listing facts, related biotech companies and news on aibio.space." --- FEMY FEMASYS INC NASDAQ · United States # FEMASYS INC (FEMY) news FEMASYS INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker FEMY, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest FEMASYS INC news We have not published a story on FEMASYS INC yet. When there is news, it will appear here. ## FEMASYS INC at a glance - **Ticker**: FEMY - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $1.4 million ### Related companies - [10x Genomics](https://aibio.space/companies/10x-genomics/) NASDAQ: TXG - [Virax Biolabs Group](https://aibio.space/companies/virax-biolabs/) NASDAQ: VRAX - [ORTHOPEDIATRICS CORP](https://aibio.space/companies/orthopediatrics/) NASDAQ: KIDS - [Personalis](https://aibio.space/companies/personalis/) NASDAQ: PSNL - [AVITA Medical](https://aibio.space/companies/avita-medical/) NASDAQ: RCEL - [RETRACTABLE TECHNOLOGIES INC](https://aibio.space/companies/retractable-technologies/) NYSE: RVP - [LivaNova](https://aibio.space/companies/livanova/) NASDAQ: LIVN - [Brainsway](https://aibio.space/companies/brainsway/) NASDAQ: BWAY ### Also on NASDAQ - [NEUROONE MEDICAL TECHNOLOGIES](https://aibio.space/companies/neuroone-medical-technologies/) NMTC - [Olema Pharmaceuticals](https://aibio.space/companies/olema-pharmaceuticals/) OLMA - [Avalyn Pharma](https://aibio.space/companies/avalyn-pharma/) AVLN - [RenovoRx](https://aibio.space/companies/renovorx/) RNXT - [enVVeno Medical](https://aibio.space/companies/envveno-medical/) NVNO - [Fortress Biotech](https://aibio.space/companies/fortress-biotech/) FBIO ## FEMASYS INC annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$2.3 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | [$1.6 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | | Research and development | [$7.6 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | [$8.2 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | | Net income (loss) | [-$18.6 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | [-$18.8 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | | Cash from operations | [-$18.7 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | [-$19.4 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | | Cash and equivalents | [$9.3 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126033157/) | [$3.5 million](https://www.sec.gov/Archives/edgar/data/1339005/000114036126012375/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $1.4 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about FEMASYS INC What is the ticker symbol of FEMASYS INC? FEMASYS INC trades under the ticker FEMY on NASDAQ. Where is FEMASYS INC listed? FEMASYS INC is listed on NASDAQ. Which country or territory is FEMASYS INC listed under? Our directory records FEMASYS INC under United States. Does aibio.space cover FEMASYS INC? aibio.space lists FEMASYS INC among 2,820 public biotech companies and publishes its news here as stories appear. What was FEMASYS INC's revenue last year? $2.3 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is FEMASYS INC profitable? FEMASYS INC reported a net loss of $18.6 million for the fiscal year ended Dec 31, 2025, and used $18.7 million of cash in operations, per its annual report to the SEC. How much does FEMASYS INC spend on research and development? $7.6 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does FEMASYS INC have? $1.4 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: FEMASYS INC Members talk about FEMASYS INC (FEMY). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at FEMASYS INC, newest first. Each line links the filing it comes from. 1. 2026-09-03 Financings Set up an at-the-market program to sell shares over time. SEC Form S-3. [Source](https://www.sec.gov/Archives/edgar/data/1339005/000114036126035625/ny20081537x1_s3.htm) 2. 2026-08-11 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1339005/000114036126032247/ef20079916_8k.htm) 3. 2026-06-24 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1339005/000114036126026239/ef20076788_8k.htm) 4. 2026-06-04 Listings Reported a reverse stock split. SEC Form 8-K (Items 7.01). [Source](https://www.sec.gov/Archives/edgar/data/1339005/000114036126023955/ef20075450_8k.htm) 5. 2026-04-29 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1339005/000114036126017805/ef20071893_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:FEMY on TradingView](https://www.tradingview.com/symbols/NASDAQ-FEMY/). ## Listing details FEMASYS INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker FEMY, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: FEMASYS INC - **Ticker**: FEMY - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/femasys/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "FEMASYS INC (FEMY) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/femasys/